Home -> Law Blog Directory -> Personal Injury Law Blogs -> New York City Personal Injury Lawyer
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: New York City Personal Injury LawyerEli Lilly Will Not Seek FDA Approval For Menopausal Osteoporosis Drug
By Chrissie Cole
Due in part to safety concerns as well as certain study results, Eli Lilly & Co. will not seek FDA approval for its developing menopausal osteoporosis drug, arzoxifene.
According to the company, the drug met late-stage study goals of reducing the risk of vertebral fracture and invasive breast cancer, but failed to meet several secondary goals including cognitive function and non-vertebral fractures.
Moreover there were serious safety concerns over increased risk of blood clots as well as gynecological-related events.
More than 9,354 postmenopausal women were involved in the 5-year study.
"The results of arzoxifene's Generations study serve as a reminder of the high risks associated with pharmaceutical innovation," said Eli Lilly Chairman and CEO John Lechleiter, in a statement.
Originally posted at InjuryBoard by Chrissie Cole
Full post as published by New York City Personal Injury Lawyer on August 20, 2009 (boomark / email).
Mitchell Report Summary
Report on Steroid Drug Use in Major League Baseball by Senator George Mitchell
Drug Manufacturer Rebates
Caremark Corp. agrees to pay $38.5 million settlement after convincing doctors to switch drug brands.
YTB International
Sales Agents Seek Class Action
Zyprexa Settlement
Costs Lilly $1.4 Billion
California Construction Workers
Seek Class Action Against BMHC
Bristol-Myers Gets Preliminary Approval of $125 MillionPlavix Settlement
Bristol-Myers Gets Preliminary Approval of $125 MillionPlavix Settlement
FDA Issues Warning Regarding Topical Ibuprofen Drug Products
Topical Ibuprofen Drug Products FDA Issues Warning Letters

Eli Lilly & Co. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2009)
Eli Lilly Zyprexa Settlement: Drug Maker to Pay Record $1.42 Billion
Courts - Judges urges Lilly to try to settle Zyprexa drug claims
Studies Show Problems With Osteoperosis Drug
Federal Circuit Affirms District Courts Extension of 30-Month FDA Stay









